Osteoblast precursor cells are found in CD34+ cells from human bone marrow.

PubWeight™: 1.16‹?› | Rank: Top 10%

🔗 View Article (PMID 9323800)

Published in Stem Cells on January 01, 1997

Authors

J L Chen1, P Hunt, M McElvain, T Black, S Kaufman, E S Choi

Author Affiliations

1: Amgen Inc., Thousand Oaks, California 91320, USA.

Articles citing this

Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing. Am J Pathol (2006) 1.75

Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis. J Am Coll Cardiol (2008) 1.55

Native human adipose stromal cells: localization, morphology and phenotype. Int J Obes (Lond) (2011) 1.46

High fat diet-induced animal model of age-associated obesity and osteoporosis. J Nutr Biochem (2010) 1.36

Characterization of circulating osteoblast lineage cells in humans. Bone (2007) 1.27

Emerging role of circulating calcifying cells in the bone-vascular axis. Circulation (2012) 1.11

Estradiol regulates expression of estrogen receptor ERalpha46 in human macrophages. PLoS One (2009) 1.10

Human embryonic stem cell-derived CD34+ cells function as MSC progenitor cells. Bone (2010) 1.10

Ameloblastin expression and putative autoregulation in mesenchymal cells suggest a role in early bone formation and repair. Bone (2010) 0.96

Osteocalcin positive CD133+/CD34-/KDR+ progenitor cells as an independent marker for unstable atherosclerosis. Eur Heart J (2012) 0.92

Parathyroid hormone stimulates circulating osteogenic cells in hypoparathyroidism. J Clin Endocrinol Metab (2010) 0.90

Polyphenol-rich cranberry juice has a neutral effect on endothelial function but decreases the fraction of osteocalcin-expressing endothelial progenitor cells. Eur J Nutr (2012) 0.89

Clinical impact of circulating CD34-positive cells on bone regeneration and healing. Tissue Eng Part B Rev (2014) 0.88

Bone marrow derived stem cells in joint and bone diseases: a concise review. Int Orthop (2014) 0.86

Association between circulating osteoprogenitor cell numbers and bone mineral density in postmenopausal osteoporosis. Osteoporos Int (2009) 0.86

Combination of conjugated linoleic acid with fish oil prevents age-associated bone marrow adiposity in C57Bl/6J mice. J Nutr Biochem (2010) 0.83

Local transplantation of granulocyte colony stimulating factor-mobilized CD34+ cells for patients with femoral and tibial nonunion: pilot clinical trial. Stem Cells Transl Med (2013) 0.82

Non-Hematopoietic Essential Functions of Bone Marrow Cells: A Review of Scientific and Clinical Literature and Rationale for Treating Bone Defects. Orthop Rev (Pavia) (2015) 0.82

Hematopoietic stem cells give rise to osteo-chondrogenic cells. Blood Cells Mol Dis (2012) 0.81

Mobilization of CD34+-progenitor cells in patients with severe trauma. PLoS One (2014) 0.78

Calcifying circulating cells: an uncharted area in the setting of vascular calcification in CKD patients. Clin Kidney J (2016) 0.78

Marker gene screening for human mesenchymal stem cells in early osteogenic response to bone morphogenetic protein 6 with DNA microarray. Genet Test Mol Biomarkers (2013) 0.75

Hydroxyapatite coating of cellulose sponges attracts bone-marrow-derived stem cells in rat subcutaneous tissue. J R Soc Interface (2009) 0.75

Controlled release of granulocyte colony-stimulating factor enhances osteoconductive and biodegradable properties of Beta-tricalcium phosphate in a rat calvarial defect model. Int J Biomater (2014) 0.75

Articles by these authors

(truncated to the top 100)

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell (1998) 17.76

To err (meiotically) is human: the genesis of human aneuploidy. Nat Rev Genet (2001) 9.08

TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev (1999) 6.93

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci U S A (1999) 5.78

Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA (1999) 4.71

Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell (1995) 4.32

RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci U S A (2000) 3.95

Solubilization and partial purification of tyrosine hydroxylase from bovine adrenal medulla. J Biol Chem (1971) 2.85

High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1. J Infect Dis (2001) 2.78

The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol (1999) 2.78

Percutaneous dilational trachestomy in the morbidly obese. Anaesthesia (2000) 2.50

L-685,458, an aspartyl protease transition state mimic, is a potent inhibitor of amyloid beta-protein precursor gamma-secretase activity. Biochemistry (2000) 2.36

A single bone marrow-derived stromal cell type supports the in vitro growth of early lymphoid and myeloid cells. Cell (1987) 2.27

Cloning and sequencing of a putative Escherichia coli [NiFe] hydrogenase-1 operon containing six open reading frames. J Bacteriol (1990) 2.20

Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. J Exp Med (2000) 2.20

Phenylketonuria due to a deficiency of dihydropteridine reductase. N Engl J Med (1975) 2.18

Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2+ ATPase), tctp, mdr1, and cg10. Antimicrob Agents Chemother (2006) 2.16

3,4-dihydroxyphenylethylamine beta-hydroxylase. Physical properties, copper content, and role of copper in the catalytic acttivity. J Biol Chem (1965) 2.13

Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. Am J Pathol (2000) 2.12

The isolation and characterization of dihydropteridine reductase from sheep liver. J Biol Chem (1972) 2.02

Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell (1994) 1.93

Budd-Chiari syndrome: etiology, diagnosis and management. Medicine (Baltimore) (1982) 1.92

Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen. Cancer Res (2000) 1.88

A randomized trial to evaluate the effectiveness of dietary advice by practice nurses in lowering diet-related coronary heart disease risk. Br J Gen Pract (1997) 1.81

Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood (1995) 1.77

Synthesis of nitrogenase in mutants of the cyanobacterium Anabaena sp. strain PCC 7120 affected in heterocyst development or metabolism. J Bacteriol (1992) 1.77

Influenza virus regulates protein synthesis during infection by repressing autophosphorylation and activity of the cellular 68,000-Mr protein kinase. J Virol (1988) 1.77

Hyperphenylalaninemia due to a deficiency of biopterin. A variant form of phenylketonuria. N Engl J Med (1978) 1.71

Clinical hypertension and its interaction with diabetes among American Indians and Alaska Natives. Estimated rates from ambulatory care data. Diabetes Care (1993) 1.70

Purification and some physical properties of phenylalanine hydroxylase from rat liver. J Biol Chem (1970) 1.69

NOD2-expressing bone marrow-derived cells appear to regulate epithelial innate immunity of the transplanted human small intestine. Gut (2007) 1.66

Reversal of hypotonia in infants with Down's syndrome by administration of 5-hydroxytryptophan. Lancet (1967) 1.62

Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum. J Pharm Pharmacol (1974) 1.60

Partial purification and characterization of tryptophan hydroxylase from rabbit hindbrain. J Biol Chem (1972) 1.53

Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50

First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50

Symptomatic nerve root changes on contrast-enhanced MR imaging after surgery for lumbar disk herniation. AJNR Am J Neuroradiol (2009) 1.48

Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J Clin Invest (1994) 1.46

In vitro activation of rat liver phenylalanine hydroxylase by phosphorylation. J Biol Chem (1976) 1.45

Malignant hyperphenylalaninaemia--current status (June 1977). J Inherit Metab Dis (1978) 1.45

Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42

A new (old) maneuver for the management of shoulder dystocia. J Fam Pract (1991) 1.41

A protein that stimulates rat liver phenylalanine hydroxylase. J Biol Chem (1970) 1.41

Deletions of 20p12 in Alagille syndrome: frequency and molecular characterization. Am J Med Genet (1997) 1.41

Health impact assessment: the contribution of the right to the highest attainable standard of health. Public Health (2009) 1.40

The meiotic competence of in-vitro matured human oocytes is influenced by donor age: evidence that folliculogenesis is compromised in the reproductively aged ovary. Hum Reprod (1998) 1.40

Neurogenic atrophy simulating facioscapulohumeral dystrophy. A dominant form. Arch Neurol (1967) 1.39

Access to CPD. Br Dent J (2007) 1.39

Interferon-alpha-2b with VMCP for induction in multiple myeloma: the Israel Myeloma Cooperative Group experience. Isr J Med Sci (1995) 1.38

Analysis and comparison of nucleotide sequences encoding the genes for [NiFe] and [NiFeSe] hydrogenases from Desulfovibrio gigas and Desulfovibrio baculatus. J Bacteriol (1989) 1.38

Veterinary nursing examinations. Vet Rec (1994) 1.38

Identity of 4a-carbinolamine dehydratase, a component of the phenylalanine hydroxylation system, and DCoH, a transregulator of homeodomain proteins. Proc Natl Acad Sci U S A (1992) 1.36

K-Sol corneal preservation. Am J Ophthalmol (1985) 1.36

Characterization of the human granulocyte-macrophage colony-stimulating factor receptor. J Biol Chem (1988) 1.35

Effects on sheep of transport by road for up to 24 hours. Vet Rec (1995) 1.34

The development and function of gamma delta T cells. Immunol Today (1990) 1.33

In vitro model for stretch-induced hypertrophy of skeletal muscle. Science (1979) 1.33

Isolation and expression of rat liver sepiapterin reductase cDNA. Proc Natl Acad Sci U S A (1990) 1.31

Tetrahydrobiopterin, a cofactor for rat cerebellar nitric oxide synthase, does not function as a reactant in the oxygenation of arginine. Proc Natl Acad Sci U S A (1991) 1.30

The presence of multiple intrinsic membrane nickel-containing hydrogenases in Desulfovibrio vulgaris (Hildenborough). Biochem Biophys Res Commun (1986) 1.30

The Hickman peel-away sheath: alternative for pediatric percutaneous nephrolithotomy. J Endourol (1997) 1.27

The stimulation of rat liver phenylalanine hydroxylase by lysolecithin and -chymotrypsin. J Biol Chem (1973) 1.27

The phenylalanine hydroxylating system from mammalian liver. Adv Enzymol Relat Areas Mol Biol (1971) 1.26

Tetrahydrobiopterin, the cofactor for aromatic amino acid hydroxylases, is synthesized by and regulates proliferation of erythroid cells. Proc Natl Acad Sci U S A (1989) 1.25

Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursors. J Cell Biochem (1999) 1.24

Enhanced protein synthesis in a cell-free system from hypertrophied skeletal muscle. Science (1967) 1.23

Glucagon stimulation of rat hepatic phenylalanine hydroxylase through phosphorylation in vivo. J Biol Chem (1978) 1.22

First observation of CP violation in the decays of B(s)0 mesons. Phys Rev Lett (2013) 1.21

Counting cross-overs: characterizing meiotic recombination in mammals. Hum Mol Genet (2000) 1.20

Proteolytic modification of the amino-terminal and carboxyl-terminal regions of rat hepatic phenylalanine hydroxylase. J Biol Chem (1986) 1.19

Analysis of the murine Hox-2.7 gene: conserved alternative transcripts with differential distributions in the nervous system and the potential for shared regulatory regions. EMBO J (1992) 1.19

Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies. J Immunol (1994) 1.19

Effect of jogging on serum low density lipoprotein cholesterol. Artery (1980) 1.18

Surgical approach to short-bowel syndrome. Experience in a population of 160 patients. Ann Surg (1995) 1.17

Chronic, nonocclusive, and maintenance-free central venous cannula in the rat. Am J Physiol (1980) 1.17

Inflammatory cytokines and vascular endothelial growth factor stimulate the release of soluble tie receptor from human endothelial cells via metalloprotease activation. Blood (1999) 1.17

Glycolysis in chick embryo cell cultures transformed by Rous sarcoma virus. Cancer Res (1968) 1.17

Purification and characterization of phenylalanine hydroxylase-stimulating protein from rat liver. J Biol Chem (1973) 1.16

Atypical phenylketonuria with normal phenylalanine hydroxylase and dihydropteridine reductase activity in vitro. Pediatrics (1977) 1.16

Chondroitin sulfate in a new cornea preservation medium. Am J Ophthalmol (1984) 1.15

Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts. Am J Epidemiol (2014) 1.14

Symptomatology in head and neck cancer: a quantitative review of 385 cases. Am J Public Health (1980) 1.14

Metabolism of the phenylalanine hydroxylation cofactor. J Biol Chem (1967) 1.14

Conversion of 6-substituted tetrahydropterins to 7-isomers via phenylalanine hydroxylase-generated intermediates. Proc Natl Acad Sci U S A (1991) 1.13

Rat liver phenylalanine hydroxylase, an iron enzyme. J Biol Chem (1972) 1.13

Complications and reoperation after Nissen fundoplication in childhood. Am J Surg (1987) 1.13

Virilizing ovarian tumor in a 2 1/2-year-old girl. J Pediatr (1967) 1.12

Letter: New forms of phenylketonuria. Lancet (1975) 1.12

Carcinocythemia (carcinoma cell leukemia). An acute leukemia-like picture due to metastatic carcinoma cells. Am J Med (1976) 1.12

The activation of rat liver phenylalanine hydroxylase by limited proteolysis, lysolecithin, and tocopherol phosphate. Changes in conformation and catalytic properties. J Biol Chem (1984) 1.12

Sclerosing cholangitis. Anatomical distribution of obstructive lesions. Ann Surg (1984) 1.12

Structure and expression of human dihydropteridine reductase. Proc Natl Acad Sci U S A (1987) 1.11

Impediments to effective fertility reduction. Contraception should be moved out of the hands of doctors. BMJ (1999) 1.11

Alpha 7 beta 1 integrin is a component of the myotendinous junction on skeletal muscle. J Cell Sci (1993) 1.11

Antimalarial drugs clear resistant parasites from partially immune hosts. Antimicrob Agents Chemother (2001) 1.10

Mutation in the 4a-carbinolamine dehydratase gene leads to mild hyperphenylalaninemia with defective cofactor metabolism. Am J Hum Genet (1993) 1.10

Prevalence of diagnosed diabetes among American Indians and Alaska Natives, 1987. Estimates from a national outpatient data base. Diabetes Care (1993) 1.10

E2F-1 blocks terminal differentiation and causes proliferation in transgenic megakaryocytes. Mol Cell Biol (1996) 1.09

Effects of acute hypertrophy on the contractile properties of skeletal muscle. Am J Physiol (1968) 1.09

Detection of hepatic phenylalanine 4-hydroxylase in classical phenylketonuria. Proc Natl Acad Sci U S A (1973) 1.08